Medtronic stentless Freestyle® porcine aortic valve replacement
Biological heart valve prostheses offer the opportunity of avoiding the risk of thromboembolic and hemorrhagic complications due to anticoagulation therapy. Current indications recommend a bioprosthesis for aortic valve replacement in patients of any age, who will not take warfarin or who have major...
| Main Authors: | , , |
|---|---|
| Format: | Book Chapter |
| Published: |
Steinkopff
2010
|
| Online Access: | http://hdl.handle.net/20.500.11937/31831 |
| _version_ | 1848753493094957056 |
|---|---|
| author | Ennker, J. Albert, A. Florath, Ines |
| author_facet | Ennker, J. Albert, A. Florath, Ines |
| author_sort | Ennker, J. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Biological heart valve prostheses offer the opportunity of avoiding the risk of thromboembolic and hemorrhagic complications due to anticoagulation therapy. Current indications recommend a bioprosthesis for aortic valve replacement in patients of any age, who will not take warfarin or who have major medical contraindications to anticoagulation therapy (Class I), in patients older than 65 years without risk factors for thromboembolism (Class IIa) and in patients under 65 years for lifestyle considerations after detailed discussion of the risks of anticoagulation versus the likelihood of a second valve replacement [1]. © 2010 Steinkopff. |
| first_indexed | 2025-11-14T08:25:23Z |
| format | Book Chapter |
| id | curtin-20.500.11937-31831 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T08:25:23Z |
| publishDate | 2010 |
| publisher | Steinkopff |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-318312017-09-13T15:17:40Z Medtronic stentless Freestyle® porcine aortic valve replacement Ennker, J. Albert, A. Florath, Ines Biological heart valve prostheses offer the opportunity of avoiding the risk of thromboembolic and hemorrhagic complications due to anticoagulation therapy. Current indications recommend a bioprosthesis for aortic valve replacement in patients of any age, who will not take warfarin or who have major medical contraindications to anticoagulation therapy (Class I), in patients older than 65 years without risk factors for thromboembolism (Class IIa) and in patients under 65 years for lifestyle considerations after detailed discussion of the risks of anticoagulation versus the likelihood of a second valve replacement [1]. © 2010 Steinkopff. 2010 Book Chapter http://hdl.handle.net/20.500.11937/31831 10.1007/978-3-7985-1869-8_26 Steinkopff restricted |
| spellingShingle | Ennker, J. Albert, A. Florath, Ines Medtronic stentless Freestyle® porcine aortic valve replacement |
| title | Medtronic stentless Freestyle® porcine aortic valve replacement |
| title_full | Medtronic stentless Freestyle® porcine aortic valve replacement |
| title_fullStr | Medtronic stentless Freestyle® porcine aortic valve replacement |
| title_full_unstemmed | Medtronic stentless Freestyle® porcine aortic valve replacement |
| title_short | Medtronic stentless Freestyle® porcine aortic valve replacement |
| title_sort | medtronic stentless freestyle® porcine aortic valve replacement |
| url | http://hdl.handle.net/20.500.11937/31831 |